Oncology
News
Cetuximab Adds No Benefit to First-Line Regimen for Metastatic Colorectal Cancer
Major Finding: Progression-free survival did not significantly differ between the standard FLOX, FLOX-cetuximab, and “stop/go” FLOX-cetuximab arms...
News
Erlotinib Trumps Chemo in Advanced NSCLC With EGFR Mutations
News
Latest News From Annual Meeting of European Society for Medical Oncology
News
NCCN's Global Reach: Footprint Extends From U.S. Payers to Foreign Practices
News
BREAKING NEWS: Encouraging Results for New Breast Cancer Treatment
News
Long-Term Breast Radiotherapy Trials at Odds Over Risk of Second Malignancies
Major Finding: No increased risk of contralateral breast cancer or second malignancies was observed after 30 years’ follow-up in the Stockholm...
News
Elevated Mitotic Rate a Potential Game Changer in Melanoma Treatment
News
Oophorectomy Halves Risk of Contralateral Breast Cancer with BRCA Mutations
Major Finding: Oophorectomy reduced the risk of contralateral breast cancer by 55% among women younger than 50 years at diagnosis.Data Source:...
News
Regional Hyperthermia Plus Chemo Helps High-Risk, Nonextremity, Soft Tissue Sarcomas
Major Finding: At 2-years, progression-free survival was 70% and disease-free survival was 56% in patients with high-risk, nonextremity, soft...
News
Age, Tumor Characteristics Predict Locoregional Failure After Neoadjuvant Breast Cancer Therapy
Major Finding: In patients treated for breast cancer with neoadjuvant chemotherapy, age, clinical tumor characteristics before therapy, and...
News
Mitomycin C Offers Alternative, but Cisplatin-Based Chemoradiation Remains Standard in Head and Neck Cancer
Major Finding: At 3 years, more patients who received weekly chemoradiation with cisplatin than MMC were free of distant metastases (HR, 0.622; P...